Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
|
Milestone Pharmaceuticals Inc. (MIST)
|
|
| Common Size Income Statement |
|
|
|
|
Annual | Quarterly | TTM |
|
| In millions, except per share items | Dec-31-21 | Dec-31-20 | Dec-31-19 | Dec-31-18 | Dec-31-17 |
| | 10-K | 10-K | 10-K | 10-K/A | S-1/A |
| Revenues | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% |
| Cost of goods sold | 46.7% | 0.0% | 0.0% | 0.0% | 100.0% |
| Gross profit | 53.3% | 100.0% | 100.0% | 100.0% | 0.0% |
| Research and development | 257.8% | -580.9% | -472.2% | -429.7% | |
| General and administrative | 82.7% | -173.2% | -78.8% | -77.8% | 18.2% |
| EBITDA | -286.5% | 852.5% | 650.5% | 607.3% | -99.9% |
| Depreciation | 0.6% | -1.6% | -0.4% | -0.3% | 0.1% |
| EBIT | -287.2% | 854.1% | 650.9% | 607.5% | -100.0% |
| Pre-tax income | -285.7% | 841.9% | 621.7% | 589.4% | 0.0% |
| Income taxes | 0.0% | 0.3% | 0.6% | -1.9% | 0.0% |
| Net income | -285.7% | 841.6% | 621.1% | 591.3% | 0.0% |
|